Opendata, web and dolomites


Personalised Medicine in Diabetic Chronic Disease Management

Total Cost €


EC-Contrib. €






Project "PROMINENT" data sheet

The following table provides information about the project.


Organization address
address: HANZEPLEIN 1
postcode: 9713 GZ

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Netherlands [NL]
 Total cost 3˙348˙480 €
 EC max contribution 1˙674˙240 € (50%)
 Programme 1. H2020-EU.1.3.4. (Increasing structural impact by co-funding activities)
 Code Call H2020-MSCA-COFUND-2016
 Funding Scheme MSCA-COFUND-DP
 Starting year 2017
 Duration (year-month-day) from 2017-09-01   to  2022-08-31


Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 


 Project objective

Diabetes is increasing rapidly from 415 million patients in 2015 to 642 million patients by 2040. As a result, it will become the leading disease worldwide, affecting 1 out of 10 persons globally and 3 out of 4 in low and middle income countries. The World Health Organisation marked World Health Day 2016 as calling for action on diabetes. Despite successful treatment of the inadequate glucose handling, diabetic patients show long-term effects of the disease such as a progressive loss of multiple organ function, in particular in the cardiovascular and renal systems. About half of the diabetic patients are at risk for renal complications associated with a markedly increased disease burden and death rate, the latter even surpassing the death rate in all treated cancer patients. The major reason for the lack of treatment efficacy is the large variation in individual response to the treatment. Consequently, we are left with a huge unmet need in the treatment of this chronic disease. A huge step forward in chronic diabetes disease management is personalised medicine. The EC has recognized the importance of personalised medicine and has started initiatives in this regard in 2016. The COFUND PROMINENT programme of the Research Institute for Drug Exploration (GUIDE) brings these fields together and introduces personalised medicine for chronic diabetes disease management. PROMINENT is focussed at setting up a dedicated doctoral training programme for 16 Early Stage Researchers (ESRs) at the University Medical Center Groningen (UMCG) and the University of Groningen (RUG). PROMINENT aims to select the best students to become excellently trained researchers, who can perform high quality research, and who subsequently have a major impact on scientific breakthroughs that foster the European society and economy in this field.


List of deliverables.
Report/s on dissemination activities Documents, reports 2020-02-12 11:09:25
Inform for each call the Project Officer Documents, reports 2020-02-12 11:09:25

Take a look to the deliverables list in detail:  detailed list of PROMINENT deliverables.


year authors and title journal last update
List of publications.
2020 Sara Sokooti, Tamas Szili-Torok, Jose L. Flores-Guerrero, Maryse C. J. Osté, António W. Gomes-Neto, Jenny E. Kootstra-Ros, Hiddo J.L. Heerspink, Margery A. Connelly, Stephan J. L. Bakker, Robin P. F. Dullaart
High-Density Lipoprotein Particles and Their Relationship to Posttransplantation Diabetes Mellitus in Renal Transplant Recipients
published pages: 481, ISSN: 2218-273X, DOI: 10.3390/biom10030481
Biomolecules 10/3 2020-04-03
2020 Sonia Roldan Munoz, Angela Lupattelli, Sieta T de Vries, Peter G M Mol, Hedvig Nordeng
Differences in medication beliefs between pregnant women using medication, or not, for chronic diseases: a cross-sectional, multinational, web-based study
published pages: e034529, ISSN: 2044-6055, DOI: 10.1136/bmjopen-2019-034529
BMJ Open 10/2 2020-04-03
2020 Angelina Osipyan, Shabnam Shaabani, Robert Warmerdam, Svitlana V. Shishkina, Harry Boltz, Alexander Dömling
Automated, Accelerated Nanoscale Synthesis of Iminopyrrolidines
published pages: , ISSN: 1433-7851, DOI: 10.1002/anie.202000887
Angewandte Chemie International Edition 2020-04-03
2019 Qian Wang, Angelina Osipyan, Markella Konstantinidou, Roberto Butera, Kumchok C. Mgimpatsang, Svitlana V. Shishkina, Alexander Dömling
Pd-Catalyzed de Novo Assembly of Diversely Substituted Indole-Fused Polyheterocycles
published pages: , ISSN: 0022-3263, DOI: 10.1021/acs.joc.9b01258
The Journal of Organic Chemistry 2020-02-12

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "PROMINENT" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email ( and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "PROMINENT" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.1.3.4.)

DOCC (2019)

Dynamics of Complex Continua

Read More  

ARDRE (2019)

Ageing, Regeneration, and Drug Research

Read More  

MemTrain (2019)

Cell Membrane Training to Advance Industrial Processes

Read More